サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：インフルエンザ診断市場：動向、機会、競合分析【2023-2028年】
市場調査レポート
商品コード
1342047

インフルエンザ診断市場：動向、機会、競合分析【2023-2028年】

Influenza Diagnostic Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

インフルエンザ診断市場：動向、機会、競合分析【2023-2028年】
出版日: 2023年08月10日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

インフルエンザ診断薬市場の動向と予測

世界のインフルエンザ診断市場は、2023年から2028年までのCAGRが4.1%で、2028年までに推定15億米ドルに達すると予測されます。この市場の主な促進要因は、慢性疾患の増加、インフルエンザを監視する政府のイニシアチブの高まり、技術的に高度なインフルエンザ診断検査のイントロダクションです。世界のインフルエンザ診断市場の将来は、診断ラボや病院・診療所市場にビジネスチャンスがあり、有望視されています。

インフルエンザ診断市場の洞察

  • Lucintelは、診断技術に関するインフルエンザ調査件数の増加や、疾病の早期診断に対する世界の意識の高まりから、予測期間中、分子診断アッセイが最大セグメントであり続けると予測しています。
  • また、病院数の増加、人々のインフルエンザ診断に対する意識の高まり、迅速診断検査機器に対する需要の高まりから、病院・診療所が最大セグメントであり続けると予測しています。
  • 北米は、高齢化人口の増加、インフルエンザの有病率の増加、主要プレイヤーの存在により、予測期間中も最大の地域です。

本レポートでは、以下の11の主要な質問について回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.市場セグメントのうち、最も有望かつ高成長なのは何か？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？また、主要企業はどのような戦略的取り組みを進めているのか？
  • Q10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度あるのか？
  • Q11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のインフルエンザ診断市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2017年から2028年までの市場動向と予測分析

  • マクロ経済動向（2017～2022年）と予測（2023～2028年）
  • 世界のインフルエンザ診断市場動向（2017～2022年）と予測（2023～2028年）
  • 製品別の世界のインフルエンザ診断市場
    • 検査キットと試薬
    • 楽器
    • その他
  • 検査タイプ別の世界のインフルエンザ診断市場
    • 従来のテスト
    • 分子診断アッセイ
    • その他
  • 最終用途産業別の世界のインフルエンザ診断市場
    • 診断研究所
    • 病院とクリニック
    • その他

第4章 2017年から2028年までの地域別の市場動向と予測分析

  • 地域別の世界のインフルエンザ診断市場
  • 北米のインフルエンザ診断市場
  • 欧州のインフルエンザ診断市場
  • アジア太平洋のインフルエンザ診断市場
  • その他地域インフルエンザ診断市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界のインフルエンザ診断市場の成長機会
    • 検査タイプ別の世界のインフルエンザ診断市場の成長機会
    • 最終用途産業別の世界のインフルエンザ診断市場の成長機会
    • 世界のインフルエンザ診断市場地域の成長機会
  • 世界のインフルエンザ診断市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のインフルエンザ診断市場の能力拡大
    • 世界のインフルエンザ診断市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • 3M
  • Hoffmann-La Roche
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific
  • Hologic
  • Quidel Corporation
  • Abbott Laboratories
  • Sekisui Diagnostics
  • SA Scientific
  • Meridian Bioscience
目次

Influenza Diagnostic Market Trends and Forecast

The future of the global influenza diagnostic market looks promising with opportunities in the diagnostic laboratory and hospital & clinic markets. The global influenza diagnostic market is expected to reach an estimated $1.5 billion by 2028 with a CAGR of 4.1% from 2023 to 2028. The major drivers for this market are increasing number of chronic diseases, growing government initiatives to monitor influenza, and introduction of technologically advanced influenza diagnostics tests.

Influenza Diagnostic Market

A more than 150-page report is developed to help in your business decisions.

Influenza Diagnostic Market by Segment

The study includes trends and forecast for the global influenza diagnostic market by product, test type, end use industry, and region, as follows:

Influenza Diagnostic Market by Product [Shipment Analysis by Value from 2017 to 2028]:

  • Test kits and reagents
  • Instruments
  • Others

Influenza Diagnostic Market by Test Type [Shipment Analysis by Value from 2017 to 2028]:

  • Traditional Tests
  • Molecular Diagnostic Assays
  • Others

Influenza Diagnostic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others

Influenza Diagnostic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Influenza Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies influenza diagnostic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the influenza diagnostic companies profiled in this report include:

  • 3M
  • Hoffmann-La Roche
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific
  • Hologic
  • Quidel Corporation
  • Abbott Laboratories
  • Sekisui Diagnostics
  • SA Scientific
  • Meridian Bioscience

Influenza Diagnostic Market Insights

  • Lucintel forecasts that molecular diagnostic assay will remain the largest segment over the forecast period due to increasing number of influenza research for diagnostic technologies along with rising awareness of early diagnosis of disease across the globe.
  • Within this market, hospitals & clinics will remain the largest segment because of rising number of hospitals, growing awareness of influenza diagnostics among people, and increasing demand for rapid diagnostic testing equipment.
  • North America will remain the largest region over the forecast period due to growing aging population, increasing prevalence of influenza, and existence of key players in this region.

Features of the Influenza Diagnostic Market

  • Market Size Estimates: Influenza diagnostic market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Influenza diagnostic market size by various segments, such as by product, test type, end use industry, and region
  • Regional Analysis: Influenza diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by product, test type, end use industry, and regions for the influenza diagnostic market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the influenza diagnostic market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

  • Q1. What is the influenza diagnostic market size?
  • Answer: The global influenza diagnostic market is expected to reach an estimated $1.5 billion by 2028.
  • Q2. What is the growth forecast for influenza diagnostic market?
  • Answer: The global influenza diagnostic market is expected to grow with a CAGR of 4.1% from 2023 to 2028.
  • Q3. What are the major drivers influencing the growth of the influenza diagnostic market?
  • Answer: The major drivers for this market are increasing number of chronic diseases, growing government initiatives to monitor influenza, and introduction of technologically advanced influenza diagnostics tests.
  • Q4. What are the major segments for influenza diagnostic market?
  • Answer: The future of the global influenza diagnostic market looks promising with opportunities in the diagnostic laboratory and hospital & clinic markets.
  • Q5. Who are the key influenza diagnostic companies?
  • Answer: Some of the key influenza diagnostic companies are as follows:
    • 3M
    • Hoffmann-La Roche
    • Becton, Dickinson and Company
    • Thermo Fisher Scientific
    • Hologic
    • Quidel Corporation
    • Abbott Laboratories
    • Sekisui Diagnostics
    • SA Scientific
    • Meridian Bioscience
  • Q6. Which influenza diagnostic segment will be the largest in future?
  • Answer:Lucintel forecasts that molecular diagnostic assay will remain the largest segment over the forecast period due to increasing number of influenza research for diagnostic technologies along with rising awareness of early diagnosis of disease across the globe.
  • Q7. In influenza diagnostic market, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region over the forecast period due to growing aging population, increasing prevalence of influenza, and existence of key players in this region.
  • Q8. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the global influenza diagnostic market by product (test kits and reagents, instruments, and others), test type (traditional tests, molecular diagnostic assays, and others), end use industry (diagnostic laboratories, hospitals & clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Influenza Diagnostic Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1. Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2. Global Influenza Diagnostic Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Influenza Diagnostic Market by Product
    • 3.3.1 Test Kits and Reagents
    • 3.3.2 Instruments
    • 3.3.3 Others
  • 3.4 Global Influenza Diagnostic Market by Test Type
    • 3.4.1 Traditional Tests
    • 3.4.2 Molecular Diagnostic Assays
    • 3.4.3 Others
  • 3.5 Global Influenza Diagnostic Market by End Use Industry
    • 3.5.1 Diagnostic Laboratories
    • 3.5.2 Hospitals & Clinics
    • 3.5.3 Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Influenza Diagnostic Market by Region
  • 4.2: North American Influenza Diagnostic Market
    • 4.2.1: North American Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
    • 4.2.2: North American Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others
  • 4.3: European Influenza Diagnostic Market
    • 4.3.1: European Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
    • 4.3.2: European Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others
  • 4.4: APAC Influenza Diagnostic Market
    • 4.4.1: APAC Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
    • 4.4.2: APAC Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others
  • 4.5: ROW Influenza Diagnostic Market
    • 4.5.1: ROW Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
    • 4.5.2: ROW Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Influenza Diagnostic Market by Product
    • 6.1.2: Growth Opportunities for the Global Influenza Diagnostic Market by Test Type
    • 6.1.3: Growth Opportunities for the Global Influenza Diagnostic Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Influenza Diagnostic Market Region
  • 6.2: Emerging Trends in the Global Influenza Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Influenza Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Influenza Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1 3M
  • 7.2 Hoffmann-La Roche
  • 7.3 Becton, Dickinson and Company
  • 7.4 Thermo Fisher Scientific
  • 7.5 Hologic
  • 7.6 Quidel Corporation
  • 7.7 Abbott Laboratories
  • 7.8 Sekisui Diagnostics
  • 7.9 SA Scientific
  • 7.10 Meridian Bioscience